HealthDay News -- Patients with a progressive fibrosis of the lungs that’s fatal within a few years of diagnosis may finally have some reason for hope. Japanese researchers say daily use of the drug pirfenidone improved the lung function and lengthened the survival of patients with the illness, called idiopathic pulmonary fibrosis (IPF).
